Tempo reale stimato
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
48,88 USD | -0,23% |
|
-0,10% | +7,43% |
Attività
Numero di dipendenti: 20
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Yue Hsin Lin
CEO | Chief Executive Officer | 46 | 27/03/18 |
Hao Yuan Chuang
DFI | Director of Finance/CFO | 40 | 01/11/20 |
Nathan L. Mata
CTO | Chief Tech/Sci/R&D Officer | 58 | 01/11/21 |
Jennifer Wu
IRC | Investor Relations Contact | - | - |
Ching Chen Chiu
PRN | Corporate Officer/Principal | 55 | 01/11/21 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Director/Board Member | 72 | 01/04/22 | |
Yi Ta Lue
BRD | Director/Board Member | 47 | 01/04/22 |
John Longo
BRD | Director/Board Member | 55 | 01/04/22 |
Yue Hsin Lin
CEO | Chief Executive Officer | 46 | 27/03/18 |
Hao Yuan Chuang
DFI | Director of Finance/CFO | 40 | 01/11/20 |
Hung Wei Chen
BRD | Director/Board Member | 43 | 01/11/21 |
Wan Shan Chen
BRD | Director/Board Member | 38 | 01/11/21 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 29 794 433 | 29 496 489 ( 99,00 %) | 0 | 99,00 % |
Coordinate società
![Indirizzo Belite Bio, Inc(BLTE)](https://cdn.zonebourse.com/static/address/136829476.png)
Settore
![Consenso](/images/consensus_flch.gif)
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
+7,43% | 1,46 Mrd | |
+26,37% | 46,56 Mrd | |
+45,38% | 41,67 Mrd | |
+0,69% | 41,16 Mrd | |
+31,07% | 32,4 Mrd | |
+22,33% | 28,18 Mrd | |
-6,35% | 28,1 Mrd | |
+49,42% | 14,52 Mrd | |
+48,43% | 13,74 Mrd | |
+3,68% | 12,17 Mrd |
- Borsa valori
- Azioni
- Azione BLTE
- Società Belite Bio, Inc